The Prevalence and Impact of Depression and Anxiety Symptoms in Patients With Non-CF Bronchiectasis
1 other identifier
observational
160
1 country
1
Brief Summary
Patients with chronic diseases are at great risk of depression and anxiety.It is known that depression and anxiety are one of the most common comorbidities associated with chronic lung diseases such as asthma and chronic obstructive pulmonary disease. However,to date,little is known about the rates and risk factors of depression and anxiety symptoms in non-CF bronchiectasis;and no large-scale prospective studies have been performed to investigate the effect of depression and anxiety on the healthy outcomes(such as number of exacerbations and hospitalizations over the ensuing year).Our purpose is to fill these gaps.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Dec 2012
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
September 14, 2012
CompletedFirst Posted
Study publicly available on registry
September 19, 2012
CompletedStudy Start
First participant enrolled
December 1, 2012
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 1, 2014
CompletedStudy Completion
Last participant's last visit for all outcomes
May 1, 2014
CompletedAugust 7, 2013
August 1, 2013
1.4 years
September 14, 2012
August 6, 2013
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
To evaluate the impact of depression and anxiety symptoms on non-CF bronchiectasis health outcomes.
Depression and anxiety are assessed at baseline using the Hospital Anxiety and Depression Scale(HADS).Health-related quality of life(HRQL) is measured using St.George's Respiratory Questionnaire(SGRQ), Leicester cough questionnaire(LCQ) and COPD assessment test(CAT) at baseline and follow-up.In the ensuing year,patients are monitored monthly by telephnone for 12 months to document the occurrence and characteristics of non-CF bronchiectasis exacerbations and hospitalizations.Patients are also encouraged to report to their investigators and research nurses whenever they experience symptom worsening.An exacerbation was defined as persistent (\>24 hour) deterioration in at least three respiratory symptoms (including cough,dyspnoea, haemoptysis, increased sputum purulence or volume, and chest pain), with or without fever (\>37.5˚ C),radiographic deterioration, systemic disturbances, or deterioration in chest signs.
one year
Secondary Outcomes (1)
To estimate the prevalence of anxiety and depression symptoms in patients with non-CF bronchiectasis
six months
Other Outcomes (1)
To identify risk factors associated with symptoms of depression and anxiety in patients with non-CF bronchiectasis
six months
Eligibility Criteria
Adults with non-CF bronchiectasis attending the First Affiliated Hospital of Guangzhou Medical College,Guangzhou,Guangdong,China
You may qualify if:
- Age ≥18 years
- HRCT diagnosed Bronchiectasis
- No fever,no worsening of respiratory symptoms,and no medication change within the 4 weeks before recruitment.
- Capable of providing written informed consent
You may not qualify if:
- cystic fibrosis
- Previous lung transplantation
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
The First Affiliated Hospital of Guangzhou Medical University
Guangzhou, Guangdong, 510000, China
Related Publications (1)
Gao YH, Guan WJ, Xu G, Gao Y, Lin ZY, Tang Y, Lin ZM, Li HM, Luo Q, Zhong NS, Birring SS, Chen RC. Validation of the Mandarin Chinese version of the Leicester Cough Questionnaire in bronchiectasis. Int J Tuberc Lung Dis. 2014 Dec;18(12):1431-7. doi: 10.5588/ijtld.14.0195.
PMID: 25517807DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
Yongchang Chen, professor
The First Affiliated Hospital of Guangzhou Medical University
- STUDY CHAIR
Nanshan Zhong, Professor
The First Affiliated Hospital of Guangzhou Medical University
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- CASE CONTROL
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- PHD
Study Record Dates
First Submitted
September 14, 2012
First Posted
September 19, 2012
Study Start
December 1, 2012
Primary Completion
May 1, 2014
Study Completion
May 1, 2014
Last Updated
August 7, 2013
Record last verified: 2013-08